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Human Immunodeficiency Virus (HIV) currently infects approximately 36.7 million people 
worldwide. Due to its crucial role in the maturation of the virus, HIV protease (PR) has been 
commonly used as a target for developing anti-retroviral drugs. However, due to the rapid 
turnover rate of HIV and the low fidelity of reverse transcriptase, mutations associated with 
resistance to each of the 9 FDA-approved protease inhibitors have decreased the efficacy of 
current available treatment. HIV protease variant PRS17 was selected by machine learning to 
represent a wide variety of drug-resistant mutants. Previous structural studies of PRS17 have 
shown a synergistic effect of its mutations result in an open flap conformation that corresponds 
with other drug-resistant mutants. In this study, small angle x-ray scattering (SAXS) and x-ray 
crystallography were used to further investigate the correlation between proteases with open 
conformations and increased drug resistance.  
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